Taiwan FDA registration 50a19af625776d1bcce8de80310d5705

"Bidi" Legionella deoxyribonucleic acid amplification analysis reagent

TW: “必帝”退伍軍人桿菌去氧核糖核酸放大分析試劑

Taiwan·Risk Class 1·BECTON, DICKINSON AND COMPANY (BD)·Registered Apr 03, 2006 – Apr 03, 2011Cancelled

Registration details

Analysis ID: 50a19af625776d1bcce8de80310d5705
Customs Code: DHA04400340001

Company information

Manufacturer: BECTON, DICKINSON AND COMPANY (BD)
Manufacturer Country: United States
Authorized Representative: Taiwan Branch of American Business Bidi Co., Ltd

Product details

Intended Use: BDProbeTM ET去氧核糖核酸物質放大分析,必須與BD ProbeTec ET System 搭配使用,利用Strand Displacement Amplification〈SDA〉之技術分析可用於具臨床症狀及其他診斷證明感染肺炎的病人.
Product Type (Level 1): C Immunology and microbiology
Product Type (Level 2): C.3300 嗜血桿菌屬血清試劑
Import Information: import

Dates and status

Registration Date: Apr 03, 2006
Expiry Date: Apr 03, 2011
Cancellation Date: Oct 26, 2012

Cancellation information

Status: Logged out
Reason: 許可證已逾有效期

About this record

Access comprehensive regulatory information for "Bidi" Legionella deoxyribonucleic acid amplification analysis reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number 50a19af625776d1bcce8de80310d5705 and manufactured by BECTON, DICKINSON AND COMPANY (BD). The authorized representative in Taiwan is Taiwan Branch of American Business Bidi Co., Ltd.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.